Comparison of survival rates among outcome studies in systemic lupus erythematosus patients
| Survival rates | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Country | Year | References | N | Follow-up time | Age | 1 Year | 2 Years | 5 Years | 10 Years | 15 Years | Remarks |
| Thailand | 2010 | This study | 213 | Median 3.6 (range 0–21.4) years | <18 years | 92.1 | 88.6 | 75.7 | 64.3 | 50.9 | All SLE, mixed therapy |
| Korea | 2007 | 14 | 77 | Mean 8.3±4.4 years | Mean 11.9±3.0 years | NA | NA | 95.4 | 91.8 | NA | LN |
| Hong Kong | 2006 | 15 | 128 | Median 5.3 (range 1–16.5) years | Range 3.6–18.6 years | NA | NA | 95 | 92 | 92 | G:B 120:8, 24 F/U ≥10 years |
| Taiwan | 2004 | 16 | 72 | Mean 7.12±0.51 years | <18 years | NA | NA | 63 | 53 | NA | LN III, IV and V |
| Serbia | 2004 | 10 | 53 | Mean 4.8±3.4 years | Mean 12.9±2.6 years | NA | NA | 88.6 | NA | NA | with renal biopsy |
| Taiwan | 2003 | 12 | 153 | Mean 6.11±9.02 years | Mean 13.1±6.0 years | NA | NA | 75.5 | 63.1 | NA | 50 deaths |
| Canada | 2002 | 13 | 67 | Mean 11 (range 5–19) years | Mean 13.2 (range 4–17) years | NA | NA | 97 | 95 | 90 | G:B=3.8:1, 4 deaths, 6 ESRD |
| Turkey | 2001 | 17 | 43 | Mean 7.2±2.8 years | Mean 12.0±2.8 years | NA | NA | 83.7 | NA | NA | with renal biopsy G:B 39:4 |
| Taiwan | 1994 | 4 | 167 | NA | Mean 13.1±2.3 (range 6–17) years | NA | NA | 91 | NA | NA | LN, G:B=153:14, 4 deaths |
B, boys; ESRD, end stage renal disease; G, girls; LN, lupus nephritis; NA, not applicable.